Paper31862005
Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
Fletcher EJR and 2 others. BMC Neurosci, 2019. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease. Papers, record 31862005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31862005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chondroitin ABC Lyase | Major topic |
| Corpus Striatum | Major topic |
| Dopaminergic Neurons | Major topic |
| Neuroprotective Agents | Major topic |
| Parkinsonian Disorders | Major topic |
| Substantia Nigra | Major topic |
| Animals | |
| Antiparkinson Agents | |
| Cell Death | |
| Male | |
| Mice, Inbred C57BL | |
| Motor Activity | |
| Oxidopamine |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22404342 | Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease. | Br J Pharmacol | 2012 | https://conductscience.org/library/papers/22404342 | PubMed |
| 2 | 18005340 | Chondroitinase ABC has a long-lasting effect on chondroitin sulphate glycosaminoglycan content in the injured rat brain. | J Neurochem | 2008 | https://conductscience.org/library/papers/18005340 | PubMed |
| 3 | 21697383 | Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury. | J Neurosci | 2011 | https://conductscience.org/library/papers/21697383 | PubMed |
| 4 | 17394547 | Mammalian-produced chondroitinase AC mitigates axon inhibition by chondroitin sulfate proteoglycans. | J Neurochem | 2007 | https://conductscience.org/library/papers/17394547 | PubMed |
| 5 | 29912283 | Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury. | Brain | 2018 | https://conductscience.org/library/papers/29912283 | PubMed |
| 6 | 15721753 | Chondroitin sulfate proteoglycans in neural development and regeneration. | Curr Opin Neurobiol | 2005 | https://conductscience.org/library/papers/15721753 | PubMed |
| 7 | 10699444 | CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. | Neuropharmacology | 2000 | https://conductscience.org/library/papers/10699444 | PubMed |
| 8 | 30323743 | Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson's Disease. | Front Cell Neurosci | 2018 | https://conductscience.org/library/papers/30323743 | PubMed |
| 9 | 22146593 | Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites. | Behav Brain Res | 2012 | https://conductscience.org/library/papers/22146593 | PubMed |
| 10 | 28713483 | The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats. | Oxid Med Cell Longev | 2017 | https://conductscience.org/library/papers/28713483 | PubMed |
| 11 | 19668200 | Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. | Nat Neurosci | 2009 | https://conductscience.org/library/papers/19668200 | PubMed |
| 12 | 29909247 | Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson's disease. | Pharmacol Rep | 2018 | https://conductscience.org/library/papers/29909247 | PubMed |
| 13 | 26044197 | Chondroitinase gene therapy improves upper limb function following cervical contusion injury. | Exp Neurol | 2015 | https://conductscience.org/library/papers/26044197 | PubMed |
| 14 | 5718510 | 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. | Eur J Pharmacol | 1968 | https://conductscience.org/library/papers/5718510 | PubMed |
| 15 | 28756859 | Improvement of activity and stability of Chondroitinase ABC I by introducing an aromatic cluster at the surface of protein. | Enzyme Microb Technol | 2017 | https://conductscience.org/library/papers/28756859 | PubMed |
| 16 | 19759203 | A clinico-pathological study of subtypes in Parkinson's disease. | Brain | 2009 | https://conductscience.org/library/papers/19759203 | PubMed |
| 17 | 15385557 | Structural and functional characterization of oversulfated chondroitin sulfate/dermatan sulfate hybrid chains from the notochord of hagfish. Neuritogenic and binding activities for growth factors and neurotrophic factors. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15385557 | PubMed |
| 18 | 8929429 | Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. | J Neurosci | 1996 | https://conductscience.org/library/papers/8929429 | PubMed |
| 19 | 24695702 | Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury. | J Neurosci | 2014 | https://conductscience.org/library/papers/24695702 | PubMed |
| 20 | 28801819 | Treadmill Exercise Prevents Increase of Neuroinflammation Markers Involved in the Dopaminergic Damage of the 6-OHDA Parkinson's Disease Model. | J Mol Neurosci | 2017 | https://conductscience.org/library/papers/28801819 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42020548 | Extracellular matrix remodelling in neurological diseases. | Nat Rev Neurol | 2026 | https://conductscience.org/library/papers/42020548 | PubMed |
| 40623478 | Inhibition of PTPRS function does not affect the survival or regeneration of dopaminergic neurons but alters synaptic function in the nigrostriatal pathway. | Neurobiol Dis | 2025 | https://conductscience.org/library/papers/40623478 | PubMed |
| 39688547 | Neuronal plasticity and its role in Alzheimer's disease and Parkinson's disease. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/39688547 | PubMed |
| 35890231 | A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson's Disease. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35890231 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31862005
GET https://conductscience.org/api/papers/v1/31862005/references?page=2